Autolus Ltd
R&D/Manufacturing
- Website
- http://www.autolus.com/
- Membership category
- Corporate Pharma
Media Works Building, 191 Wood Lane, London, W12 7FP, United Kingdom
Autolus Ltd at a glance
Autolus Therapeutics plc (Nasdaq: AUTL) is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.
About Autolus Ltd
Autolus Therapeutics plc (Nasdaq: AUTL) is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defence mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of haematological malignancies and solid tumours.
